SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-215317
Filing Date
2019-08-07
Accepted
2019-08-07 16:08:11
Documents
105
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d768753d10q.htm   iXBRL 10-Q 5843206
2 EX-31.1 d768753dex311.htm EX-31.1 10694
3 EX-31.2 d768753dex312.htm EX-31.2 10699
4 EX-32 d768753dex32.htm EX-32 4290
  Complete submission text file 0001193125-19-215317.txt   19313925

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA teva-20190630.xsd EX-101.SCH 88524
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE teva-20190630_cal.xml EX-101.CAL 61626
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE teva-20190630_def.xml EX-101.DEF 586291
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20190630_lab.xml EX-101.LAB 596615
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20190630_pre.xml EX-101.PRE 631425
10 EXTRACTED XBRL INSTANCE DOCUMENT d768753d10q_htm.xml XML 4651155
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16174 | Film No.: 191005514
SIC: 2834 Pharmaceutical Preparations